Lymphoma

LYMPHOMA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Most Blood Cancer Drug Trials Are Not Randomized, Use Surrogate Endpoints

Of more than 2500 trials analyzed, 21% were randomized.
Eponyms in Oncology: Waldenström Macroglobulinemia

This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Waldenström macroglobulinemia.
Eponyms in Oncology: Virchow’s Node

This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Virchow’s node.
Phthalates in Medications May Increase Risk of Childhood Cancers

Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
Eponyms in Oncology: Hodgkin Lymphoma

This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Hodgkin lymphoma.

LYMPHOMA NEWS

Researchers have identified actionable alterations in nearly 38% of patients with cancer, and almost 18% of patients were assigned to treatments based on their molecular profiling results.

Molecular Profiling Can Guide Treatment After Recurrence in Young Cancer Patients

May 11, 2022

Black female patient talking to doctor.

Response to CAR T-Cell Therapy Similar for Minority Patients

May 6, 2022

Doctor talking to patient.

Disparity in Access to CAR-T Therapy Associated With Lower Income Neighborhoods

May 5, 2022

A clinician prepares for hematopoietic stem cell transplantation.

Results Support Allo-HSCT After CAR-T Failure in Large B-Cell Lymphoma

April 29, 2022

CoVac-1 Induces T-Cell Responses in Patients With B-Cell Deficiencies

April 28, 2022

Next post in Lymphoma

Man receiving vaccination shot.

Vaccine-Induced Responses to Omicron, Delta Impaired in Non-Hodgkin Lymphoma Patients